Showing results (151-160 of 183) with videos related to
Sort By:
Pageof 19
Journal of Neuro-Oncology|January 5, 2008
A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149)Lode J Swinnen, Cathryn Rankin, Hetty Carraway, et al.Neurology|October 21, 2005
Capecitabine-induced multifocal leukoencephalopathy: a report of five casesA Videnovic, I Semenov, R Chua-Adajar, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|September 20, 2012
The impact of enrollment in clinical trials on survival of patients with glioblastomaTal Shahar, Erez Nossek, David M Steinberg, et al.Neuro-Oncology|September 10, 2008
Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131Michael A Vogelbaum, Brian Berkey, David Peereboom, et al.Journal of Neuro-Oncology|January 15, 2018
Neurologic complications of immune checkpoint inhibitorsAvi Fellner, Chen Makranz, Michal Lotem, et al.International Journal of Clinical Oncology|November 20, 2014
A Phase III study of radiation therapy (RT) and O⁶-benzylguanine + BCNU versus RT and BCNU alone and methylation status in newly diagnosed glioblastoma and gliosarcoma: Southwest Oncology Group (SWOG) study S0001Deborah T Blumenthal, Cathryn Rankin, Keith J Stelzer, et al.Cancer|June 4, 2008
External beam irradiation and the combination of cisplatin and carmustine followed by carmustine alone for the treatment of high-grade glioma: a phase 2 Southwest Oncology Group trialDeborah T Blumenthal, Cathryn Rankin, Harmon J Eyre, et al.Journal of Neuro-Oncology|August 18, 2016
Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patientsDeborah T Blumenthal, Addie Dvir, Alexander Lossos, et al.Plos One|December 5, 2012
Hemodynamic response imaging: a potential tool for the assessment of angiogenesis in brain tumorsDafna Ben Bashat, Moran Artzi, Haim Ben Ami, et al.AJNR. American Journal of Neuroradiology|July 9, 2016
Early Biomarkers from Conventional and Delayed-Contrast MRI to Predict the Response to Bevacizumab in Recurrent High-Grade GliomasD Daniels, D Guez, D Last, et al.Pageof 19